Beractant
| Clinical data | |
|---|---|
| Trade names | Survanta, Alveofact |
| Legal status |
|
| Routes of administration | Endotracheal |
| Identifiers | |
| ATC code | None |
| ChemSpider | none |
| UNII |
S866O45PIG  |
| ChEMBL |
CHEMBL1201624  |
| (what is this?) (verify) | |
Beractant, also known by the trade name of Survanta,[1] is a modified bovine surfactant extract. As an intratracheal suspension, it can be used for the prevention and treatment of neonatal respiratory distress syndrome.
References
This article is issued from Wikipedia - version of the Thursday, November 19, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.